Senate Panel OKs Antitrust Package Aimed At Drug Pricing
The U.S. Senate Judiciary Committee passed a slew of bills Thursday that would increase the Federal Trade Commission's ability to crack down on a variety of anti-competitive practices that lawmakers say...To view the full article, register now.
Already a subscriber? Click here to view full article